United Therapeutic (UTHR)

$101.01 0.00 (0.00%)

19:47 EDT UTHR Stock Quote Delayed 30 Minutes

Volume:

Previous Close $101.01

Market Cap 4.40B

PE Ratio 9.19

EPS 10.99

Volume (Avg. Vol.)

Day's Range 101.01 - 101.01

52-Week Range 75.58 - 127.79

Dividend & Yield N/A (N/A)

UTHR Stock Predictions, Articles, and United Therapeutic News

From InvestorPlace
From the Web

The 7 Best Pharmaceutical Stocks That Go Beyond the Covid-19 Chase

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 14, 2020

There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.

7 “Strong Buy” Healthcare Stocks to Buy Now

By Maya Sasson, Writer, TipRanks May 8, 2020

Amid the COVID-19 pandemic, the investing pros say that it’s still possible to unmask names poised to take off on an upward trajectory.

8 Biotech Stocks to Watch After the Q2 Earnings Season

By Chris Lau, InvestorPlace Contributor Aug 20, 2019

Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.

Why Arena Pharmaceuticals Stock Is Soaring Today

By William White, InvestorPlace Writer Nov 15, 2018

Arena Pharmaceuticals stock was soaring Thursday on news of a license deal with United Therapeutics (UTHR) for ralinepag.

New Development Partnership Could Pay Off Big for MannKind Stock

By Chris Lau, InvestorPlace Contributor Sep 5, 2018

MannKind scored a collaboration deal with biotechnology giant, United Therapeutics. This development partnership could pay off big.

Why MannKind Stock Is Skyrocketing Today

By William White, InvestorPlace Writer Sep 4, 2018

MannKind (MNKD) stock was flying high on Tuesday following the announcement of a $45-million deal with United Therapeutics (UTHR).

Compare Brokers

United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk

By Karl Utermohlen, InvestorPlace Writer Aug 4, 2017

United Therapeutics (UTHR) shares skyrocketed Friday amidst rumors that the company may be the subject of a takeover by a pharma giant soon.

Can 3D Systems Corporation (DDD) Stock Keep Up Its Go-Go 2017?

By Chris Lau, InvestorPlace Contributor May 2, 2017

3D Systems is up more than 20% so far this year, but DDD stock needs a first-quarter earnings beat to keep the momentum rolling.

Why General Motors Company (GM), Acorda Therapeutics Inc (ACOR) and United Therapeutics Corporation (UTHR) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Apr 3, 2017

Acorda Therapeutics (ACOR), General Motors (GM) and United Therapeutics (UTHR) investors ended up wishing last weekend was a three-day weekend.

4 Biotech Stocks to Buy After Clinton’s Defeat

By Profit Scanner Nov 14, 2016

The market was pricing in a Clinton win, and with it, the downfall of biotech stocks. But these biotechs stand to win under President Trump.

52 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

27 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 7, 2016

This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Compare Brokers